FOR LABORATORY RESEARCH USE ONLY. Not for human or veterinary use, not for consumption, not medicines. Research use policy
UK only · Prepared to order · approx. 7 days + Royal Mail Tracked 24 · No international shipping
Policies · Draft

Research Use Policy

DRAFT – FOR SOLICITOR REVIEW. This document is a working draft prepared for review by a qualified solicitor in England & Wales. It is not legal advice and must not be relied on or published as final. Items in [brackets] need completing. Last drafted: [DATE].

Britpep supplies peptides and related compounds solely as research reagents for in-vitro laboratory and analytical work by qualified persons.

1. Permitted use

  • In-vitro research, assay development, analytical reference and method validation in an appropriately equipped laboratory.

2. Prohibited use

  • Administration to humans or animals by any route, or human consumption in any form.
  • Use as, or in the manufacture of, a medicine, food, food supplement, cosmetic or veterinary product.
  • Resale or supply to individuals for personal use.
  • [Solicitor to confirm whether any in-vivo animal research supply should be permitted under ASPA 1986 licences, or excluded entirely. Current draft: excluded.]

3. Our commitments

  • We do not make claims of any therapeutic, health or cosmetic benefit, and we do not provide dosing, administration or preparation-for-use information.
  • We do not stock any product that holds a UK marketing authorisation as a medicine, and we do not supply injection devices or consumables. [DRAFT – solicitor to confirm this wording against the final catalogue]
  • Every order requires declarations of research use, age 18+ and institutional/professional status. Trade accounts are verified before first order.
  • We will refuse or cancel orders, and may close accounts, where we have reason to believe products may be used outside the laboratory. We may report suspicious activity to the relevant authorities.

4. Regulatory note

[Solicitor to review the position of each listed product under the Human Medicines Regulations 2012 (including the definition of a medicinal product by presentation and by function), the Misuse of Drugs Act 1971, the Psychoactive Substances Act 2016, the anti-doping framework and MHRA guidance, and to advise on any product that should be removed.]

5. Contact

Questions about this policy: sales@britpep.co.uk.

DRAFT – FOR SOLICITOR REVIEW. This document is a working draft prepared for review by a qualified solicitor in England & Wales. It is not legal advice and must not be relied on or published as final. Items in [brackets] need completing. Last drafted: [DATE].